Mometasone Furoate Articles
German Pharma produced 37 new drugs in 2009
8 January 2010
Nycomed reports satisfactory 3rd-quarter 2009 performance, despite generic erosion of pantoprazole sales
13 November 2009
Swine flu vaccine shortage likely in the USA
19 October 2009
Par Pharma starts shipping generic Miacalcin
9 June 2009
NasalFent gives earlier pain relief than IRMS
3 June 2009
NasalFent gives cancer-pain relief in five min
11 May 2009
Sepracor's 1st-qtr revenues jump 3%
5 May 2009
Archimedes submits NasalFent MAA
28 April 2009
CHMP meeting sees good news for AZ, but not for Teva
24 April 2009
Schering-Plough profits beat forecasts
21 April 2009
Viroblock's nose spray shows anti-flu effect in vivo
1 April 2009
CyDex presents strong data for nasal sprays
23 March 2009
Prasco to distribute GSK generics
16 March 2009
Schering-Plough finally back in profit after Organon buy; exceeds expectations, pleasing shareholders
9 February 2009
Leconotide's potential for non-opioid pain relief
9 February 2009
MedImmune files MAA for LAIV
12 January 2009
Joint Swiss/Taiwan development of vaccines for avian flu
22 December 2008
DOR gets $1.5M from Sigma under orBec deal
8 December 2008
FDA accepts Meda's filing for new form of azelastine
3 November 2008
S-P profit falls 21%, still up on predictions
27 October 2008
US FDA clears Meda's new Astepro
27 October 2008
Archimedes' NasalFent meets Ph III efficacy endpoint
20 October 2008
AstraZeneca's Zomig nasal spray good for cluster headache
15 September 2008
Meda settles Astelin patent case with Cobalt
1 September 2008
SinoFresh nose spray controls MRSA in vivo
1 September 2008
China Sky One nasal spray for rheumatic disease
1 September 2008
Archimedes licenses German rights to Molteni's Oramorph
18 August 2008
S-P profit down again on Organon charges
28 July 2008
S-P gains approval for hayfever drug in Japan
28 July 2008
Meda resolves patent suits against Apotex
28 April 2008
Meda acquires rights to Orexo drugs
21 April 2008
S-P's 4th-qtr 2007 results hit by Organon buy
18 February 2008
FDA approves S-P's Asmanex Twisthaler
14 February 2008
Stock Commentary - New York week to Feb 4, 2008
11 February 2008
Nycomed licenses US rights to ciclesonide drugs to Sepracor in deal worth up to $430M
4 February 2008
Inspire initiates Ph III epinastine nose spray trial
10 December 2007
1 in 3 cardiac patients does not believe flu vacc needed
12 November 2007
S-P's 3rd-qtr 2007 net income surges 149%
29 October 2007
Alcon amends NDA for Patanase
15 October 2007
Ph II capsitonin trial yields more positive data
6 August 2007
S-P's 2nd-quarter 2007 EPS doubles to $0.34
30 July 2007
US FDA approves GSK's Veramyst for allergy
7 May 2007
Schering-Plough 1st-qtr profits leap 55%
30 April 2007
Stock Commentary - New York week to April 16, 2007
23 April 2007
Archimedes initiates Ph III Nasalfent trial
5 February 2007
Bentley initiates Ph II trial of insulin nose spray
13 November 2006
Evolutec raises L2.8 million
30 October 2006
S-P's 3rd-qtr 2006 net income improves
30 October 2006
Nastech completes response to FDA on osteoporosis spray
9 October 2006
Nastech begins dose ranging assessment of PYY3-36
28 August 2006
Nastech's oesteoporosis ANDA rejected by FDA
24 July 2006
Stock Commentary - New York week toJune 26, 2006
3 July 2006
Nastech and P&G collaborate on PTH1-34 nasal spray
12 June 2006
Barr challenges Nasacort patent
15 May 2006
IFPMA members work on avian flu vaccs
15 May 2006
Nastech signs PTH1-34 accord with P&G
6 February 2006
Rigel shares hit by R112's Ph II failure
12 December 2005
Schering-Plough's Nasonex "superior in scent and taste to GSK's Flonase"
12 September 2005
Unigene shares leap on US Fortical clearance
22 August 2005
Schering-Plough expands in Asia Pacific
18 July 2005
Nastech starts Ph I trial of PTH1-34
11 July 2005
Zomig effective in adolescent migraine
4 July 2005
Migraine sufferers dissatisfied with current therapies
25 April 2005
Schering-Plough back in profit for 1st-qtr
22 April 2005
S-P's Asmanex cleared in USA for asthma
11 April 2005
Biolipox completes Phase I for novel hay fever treatment
28 February 2005
Zomig induces rapid relief from migraine
21 February 2005
Nastech's Nascobal gets FDA approval
7 February 2005
New study confirms Zomig long-term safety
31 January 2005
Patients prefer AstraZeneca's Zomig
17 January 2005
New use for Schering-Plough's Nasonex
10 January 2005
US appro for Taro's mometasone furoate ointment
13 December 2004
Alpharma forecasts loss for 3rd qtr
25 October 2004
Promo activity in Rx allergy market assessed
11 October 2004
AstraZeneca's Zomig is top triptan in Europe
8 March 2004
Unigene gets approvable letter for Fortical
19 January 2004
Nascobal Nasal spray NDA submitted to FDA
5 January 2004
Nastech submits calcitonin nasal spray NDA
5 January 2004
Atrix gains appro for generic mometasone ointment
24 November 2003
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
